Anthelios 40 is a MUST HAVE for everyone who is serious about sun protection. Since this product provides broad spectrum sun protection using SPF 40 and Mexoryl SX, I know my patients are protected from dangerous UV rays that can cause skin cancer as well as aging.
- Dr. Debra Wattenberg
Dermatology and Dermatologic Surgery
Sunscreen cream with SPF 40 for sun-sensitive skin
La Roche-Posay suggests that you visit a skincare physician for a professional skin diagnosis to ensure that this product best addresses your skin’s needs.
Mexoryl™ SX is a sun filter in the only sunscreen formulas that have been specifically approved by the FDA for protection against short UVA rays.
Recommended For
All adults and children (6 months and older) concerned with the prevention of skin cancer, skin aging, and hyperpigmentation.
Sun-sensitive skin.
Product Information
FDA approved. ANTHELIOS 40 sunscreen cream with SPF 40, the highest UVA & UVB protection in a sunscreen with Mexoryl™ SX, specifically tested on photosensitive skin. Recommended for outdoor use.
WINNER BEST FACIAL SUNSCREEN InStyle 2009 Best Beauty Buys
Benefits
High UVA protection with 3% Mexoryl™ SX (highest concentration)
SPF 40
High photostability (resists losing efficacy in the sun)
Broad-spectrum UVA/UVB protection
Tested safe on photosensitive skin
Tested safe for children
Non-comedogenic
Dry finish texture (non-greasy)
Suitable for sensitive skin
Fragrance-free, PABA-free
Dermatologist and allergy-tested
Clinical studies
1 year safety study on patients with PMLE¹
Clinical pediatric safety study²
Key Ingredients
Mexoryl™ SX 3% protects against short UVA rays and is photostable on its own
Octocrylene 10% protects against UVB rays
Avobenzone 2% protects against long UVA rays and is stabilized by Octocrylene
Titanium Dioxide 5% provides enhanced overall UVA and UVB protection
Directions
Apply evenly 15 minutes before sun exposure
Reapply as needed or after towel drying, swimming or perspiring
Children under 6 months of age: ask a doctor
Disclaimer
¹Data on file: 1 year safety study conducted on 475 patients with photosensitive skin including those with PMLE
²Data on file: Clinical 6-month pediatric safety study conducted on 135 children aged 6 months to 12 years
